Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid A adjuvant vaccine

Infection and Immunity

Volumn 66, Issue 2, 1998, Pages 823-826

  Sasaki, S ^a   Hamajima, K ^a   Fukushima, J ^a   Ihata, A ^a   Ishii, N ^a   Gorai, I ^a   Hirahara, F ^a   Mohri, H ^a   Okuda, K ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; HUMORAL ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOLOGICAL ADJUVANT; PHOSPHORYL LIPID A; REV PROTEIN; SECRETORY IMMUNOGLOBULIN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; DRUG MIXTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; INHALATIONAL DRUG ADMINISTRATION; INOCULATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031906873     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.2.823-826.1998     Document Type: Article

References (30)